1Bunn PA Jr,Kelly K.New combinations in the treatment of lung cancer:a time for optimism[J].Chest,2000,117(4 Suppl 1):138S-143S.
2Rusthoven JJ,Eisenhauer E,Butts C,et al.Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer:A phase II study.National Cancer Institute of Canada Clinical Trials Group[J].J Clin Oncol,1999,17(4):1194-1199.
3Clarke SJ,Abratt R,Goedhals L,et al.Phase II trial of pemetrexed disodium (ALIMTA,LY231514) in chemotherapy-naive patients with advanced non-small-cell lung cancer[J].Ann Oncol,2002,13(5):737-741.
4Adjei AA,Nair S,Reuter N,et al.Pemetrexed/gemcitabine as front-line therapy for advanced NSCLC:A randomized,phase Ⅱtrial of three schedules[J].Proc Am Soc Clin Oncol,2004,23:A 7070.
5Monnerat C,Le Chevalier T,Kelly K,et al.Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer[J].Clin Cancer Res,2004,10(16):5439-5446.
6Treat J,McCleod M,Mintzer D,et al.Pemetrexed plus gemcitabine as front-line therapy for patients with advanced stage non-small cell lung cancer[J].Proc Am Soc Clin Oncol,2004,23:A7130.
7Koshy S,Obasaju C,Fossella FV,et al.Update of phase1 ⅡTrial of pemetrexed plus carboplatin in patients with advanced non-sm all-cell lung cancer[J].Proc Am Soc Clin Oncol,2004,22:A7074.
8Hanna N,Shepherd FA,Fossella FV,et al.Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy[J].J Clin Oncol,2004,22(9):1589-1597.
